323 related articles for article (PubMed ID: 19012670)
1. What are the nursing implications when using paliperidone prolonged release for people with schizophrenia.
Jones A
J Psychiatr Ment Health Nurs; 2008 Dec; 15(10):792-9. PubMed ID: 19012670
[TBL] [Abstract][Full Text] [Related]
2. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.
Fowler JA; Bettinger TL; Argo TR
Clin Ther; 2008 Feb; 30(2):231-48. PubMed ID: 18343262
[TBL] [Abstract][Full Text] [Related]
3. Paliperidone: new drug. Just a metabolite of risperidone, a neuroleptic soon off-patent.
Prescrire Int; 2007 Dec; 16(92):236-7. PubMed ID: 18092400
[TBL] [Abstract][Full Text] [Related]
4. A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia.
Berwaerts J; Cleton A; Rossenu S; Talluri K; Remmerie B; Janssens L; Boom S; Kramer M; Eerdekens M
J Psychopharmacol; 2010 Jul; 24(7):1011-8. PubMed ID: 19825908
[TBL] [Abstract][Full Text] [Related]
5. Paliperidone ER versus risperidone for neurocognitive function in patients with schizophrenia: a randomized, open-label, controlled trial.
Kim SW; Chung YC; Lee YH; Lee JH; Kim SY; Bae KY; Kim JM; Shin IS; Yoon JS
Int Clin Psychopharmacol; 2012 Sep; 27(5):267-74. PubMed ID: 22809972
[TBL] [Abstract][Full Text] [Related]
6. Paliperidone extended-release for the treatment of schizophrenia.
Marino J; Caballero J
Pharmacotherapy; 2008 Oct; 28(10):1283-98. PubMed ID: 18823223
[TBL] [Abstract][Full Text] [Related]
7. Expected clinical benefits of paliperidone extended-release formulation when compared with risperidone immediate-release.
Pani L; Marchese G
Expert Opin Drug Deliv; 2009 Mar; 6(3):319-31. PubMed ID: 19317589
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled study of 2 dose ranges of paliperidone extended-release in the treatment of subjects with schizoaffective disorder.
Canuso CM; Lindenmayer JP; Kosik-Gonzalez C; Turkoz I; Carothers J; Bossie CA; Schooler NR
J Clin Psychiatry; 2010 May; 71(5):587-98. PubMed ID: 20492853
[TBL] [Abstract][Full Text] [Related]
9. Medication satisfaction in schizophrenia: a blinded-initiation study of paliperidone extended release in patients suboptimally responsive to risperidone.
Canuso CM; Grinspan A; Kalali A; Damaraju CV; Merriman U; Alphs L; Awad AG
Int Clin Psychopharmacol; 2010 May; 25(3):155-64. PubMed ID: 20216424
[TBL] [Abstract][Full Text] [Related]
10. Molecule of the month. Paliperidone.
Drug News Perspect; 2007 Jun; 20(5):333. PubMed ID: 17878961
[No Abstract] [Full Text] [Related]
11. A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia.
Luthringer R; Staner L; Noel N; Muzet M; Gassmann-Mayer C; Talluri K; Cleton A; Eerdekens M; Battisti WP; Palumbo JM
Int Clin Psychopharmacol; 2007 Sep; 22(5):299-308. PubMed ID: 17690599
[TBL] [Abstract][Full Text] [Related]
12. Safety and tolerability of oral paliperidone extended-release tablets in elderly patients with schizophrenia: a double-blind, placebo-controlled study with six-month open-label extension.
Tzimos A; Samokhvalov V; Kramer M; Ford L; Gassmann-Mayer C; Lim P; Eerdekens M
Am J Geriatr Psychiatry; 2008 Jan; 16(1):31-43. PubMed ID: 18165460
[TBL] [Abstract][Full Text] [Related]
13. Obsessive-compulsive symptoms induced by long-acting injectable paliperidone in a patient with schizophrenia: a case report.
Vázquez-Bourgon J; Rodríguez-Rodríguez P; Gómez-Ruíz E; Artal J; Crespo-Facorro B
Ann Clin Psychiatry; 2014 Nov; 26(4):301-2. PubMed ID: 25401718
[No Abstract] [Full Text] [Related]
14. Efficacy and safety of paliperidone extended-release tablets: results of a 6-week, randomized, placebo-controlled study.
Marder SR; Kramer M; Ford L; Eerdekens E; Lim P; Eerdekens M; Lowy A
Biol Psychiatry; 2007 Dec; 62(12):1363-70. PubMed ID: 17601495
[TBL] [Abstract][Full Text] [Related]
15. Paliperidone extended-release tablets in schizophrenia patients previously treated with risperidone.
Canuso CM; Youssef EA; Bossie CA; Turkoz I; Schreiner A; Simpson GM
Int Clin Psychopharmacol; 2008 Jul; 23(4):209-15. PubMed ID: 18545059
[TBL] [Abstract][Full Text] [Related]
16. Paliperidone for treatment of schizophrenia.
Nussbaum AM; Stroup TS
Schizophr Bull; 2008 May; 34(3):419-22. PubMed ID: 18375569
[TBL] [Abstract][Full Text] [Related]
17. Paliperidone overdose in a patient with schizophrenia.
Chang JP; Huang CC; Su KP
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):418. PubMed ID: 19995588
[No Abstract] [Full Text] [Related]
18. Possible neuroleptic malignant syndrome during paliperidone administration: a case report.
Mantas C; Kalabokis G; Goulia P; Tourlakopoulos A; Hyphantis T; Mavreas V
J Clin Psychopharmacol; 2010 Feb; 30(1):89-91. PubMed ID: 20075663
[No Abstract] [Full Text] [Related]
19. Paliperidone extended-release: does it have a place in antipsychotic therapy?
Gahr M; Kölle MA; Schönfeldt-Lecuona C; Lepping P; Freudenmann RW
Drug Des Devel Ther; 2011 Mar; 5():125-46. PubMed ID: 21448450
[TBL] [Abstract][Full Text] [Related]
20. [Paliperidone, risperidone].
Takeuchi K; Sanjo K; Sakai A
Nihon Rinsho; 2013 Apr; 71(4):654-9. PubMed ID: 23678595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
